Insider · CIK 0001248093
Emil D Kakkis
Files at RARE (Ultragenyx Pharmaceutical Inc.). First filing Dec 11, 2024, latest Mar 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RARE: Ultragenyx Pharmaceutical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Ultragenyx Pharmaceutical Inc. | $4.2M 98,434 shares | -5% | - | |
| 23Weak | Ultragenyx Pharmaceutical Inc. | $495k 11,727 shares | -1% | - | |
| 21Weak | Ultragenyx Pharmaceutical Inc. | $414k 8,273 shares | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock10b5-1 | +43,268 | $0.00 | $0 | 607,873 | Mar 4, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock10b5-1 | +107,292 | $0.00 | $0 | 715,165 | Mar 4, 2025 |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock10b5-1 | -73,434 | $42.10 | $3.1M | 641,731 | Mar 4, 2025 |
| Feb 28, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stockindirect: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200910b5-1 | -25,000 | $42.48 | $1.1M | 2,158,985 | Mar 4, 2025 |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +78,448 | $0.00 | $0 | 78,448 | Mar 4, 2025 |
| Dec 30, 2024 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stockindirect: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200910b5-1 | -11,727 | $42.23 | $495k | 2,183,985 | Dec 31, 2024 |
| Dec 9, 2024 | RARE Ultragenyx Pharmaceutical Inc. | GGift Common Stockindirect: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200910b5-1 | -20,000 | $0.00 | $0 | 2,203,985 | Dec 11, 2024 |
| Dec 10, 2024 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stockindirect: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200910b5-1 | -8,273 | $50.00 | $414k | 2,195,712 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.